337 related articles for article (PubMed ID: 38391949)
1. Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry.
Liguori GL
Cells; 2024 Feb; 13(4):. PubMed ID: 38391949
[TBL] [Abstract][Full Text] [Related]
2. The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives.
Azam Z; Quillien V; Wang G; To ST
Acta Oncol; 2019 Mar; 58(3):353-362. PubMed ID: 30632857
[TBL] [Abstract][Full Text] [Related]
3. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
4. Breaking through the glioblastoma micro-environment via extracellular vesicles.
Simon T; Jackson E; Giamas G
Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
[TBL] [Abstract][Full Text] [Related]
5. Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma.
Robinson SD; Samuels M; Jones W; Gilbert D; Critchley G; Giamas G
BMC Cancer; 2023 Oct; 23(1):939. PubMed ID: 37798728
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles throughout development: A potential roadmap for emerging glioblastoma therapies.
Fernandes CFL; Coelho BP; Souza MCDS; Boccacino JM; Soares SR; Araújo JPA; Melo-Escobar MI; Lopes MH
Semin Cell Dev Biol; 2023 Jan; 133():32-41. PubMed ID: 35697594
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide affects Extracellular Vesicles Released by Glioblastoma Cells.
André-Grégoire G; Bidère N; Gavard J
Biochimie; 2018 Dec; 155():11-15. PubMed ID: 29454008
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
Lemée JM; Clavreul A; Menei P
Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
[TBL] [Abstract][Full Text] [Related]
9. Advancements and Technical Considerations for Extracellular Vesicle Isolation and Biomarker Identification in Glioblastoma.
Cumba Garcia LM; Bouchal SM; Bauman MMJ; Parney IF
Neurosurgery; 2023 Jul; 93(1):33-42. PubMed ID: 36749103
[TBL] [Abstract][Full Text] [Related]
10. Pathological and Therapeutic Significance of Tumor-Derived Extracellular Vesicles in Cancer Cell Migration and Metastasis.
Liguori GL; Kralj-Iglič V
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760395
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.
Dai J; Jiang Y; Hu H; Zhang S; Chen Y
Pathol Oncol Res; 2024; 30():1611549. PubMed ID: 38379858
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
14. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.
Li Z; Fu WJ; Chen XQ; Wang S; Deng RS; Tang XP; Yang KD; Niu Q; Zhou H; Li QR; Lin Y; Liang M; Li SS; Ping YF; Liu XD; Bian XW; Yao XH
J Exp Clin Cancer Res; 2022 Feb; 41(1):74. PubMed ID: 35193644
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide increases heat shock proteins in extracellular vesicles released from glioblastoma cells.
Kıyga E; Adıgüzel Z; Önay Uçar E
Mol Biol Rep; 2022 Sep; 49(9):8701-8713. PubMed ID: 35752701
[TBL] [Abstract][Full Text] [Related]
16. Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism.
Wang X; Yu X; Xu H; Wei K; Wang S; Wang Y; Han J
Cell Death Dis; 2022 Apr; 13(4):344. PubMed ID: 35418162
[TBL] [Abstract][Full Text] [Related]
17. Roles of extracellular vesicles in glioblastoma: foes, friends and informers.
Lunavat TR; Nieland L; Vrijmoet AB; Zargani-Piccardi A; Samaha Y; Breyne K; Breakefield XO
Front Oncol; 2023; 13():1291177. PubMed ID: 38074665
[TBL] [Abstract][Full Text] [Related]
18. Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat Glioblastoma.
Surendran A; Jenner AL; Karimi E; Fiset B; Quail DF; Walsh LA; Craig M
J Pharmacol Exp Ther; 2023 Oct; 387(1):66-77. PubMed ID: 37442619
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
